CD14 deficiency impacts glucose homeostasis in mice through altered adrenal tone

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Young, James L ^a   Mora, Alfonso ^a   Cerny, Anna ^a   Czech, Michael P ^a   Woda, Bruce ^a   Kurt Jones, Evelyn A ^a   Finberg, Robert W ^a   Corvera, Silvia ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; GLUCOSE; INSULIN; NORADRENALIN; RECOMBINANT HUMAN INSULIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; FATTY ACID; LIPID; LIPOPOLYSACCHARIDE;

ADRENAL GLAND; ADRENAL MEDULLA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HYPOGLYCEMIA; INNATE IMMUNITY; INSULIN SENSITIVITY; LIPID DIET; MOUSE; NONHUMAN; URINARY EXCRETION; WILD TYPE; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; DIET RESTRICTION; DRUG EFFECT; FAT INTAKE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMAN; METABOLISM; MOUSE MUTANT; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PERITONEUM MACROPHAGE; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); MUS;

ADIPOSITY; ADRENAL GLANDS; ANIMALS; ANTIGENS, CD14; BODY WEIGHT; DIETARY FATS; FASTING; FATTY ACIDS; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; HYPOGLYCEMIA; INSULIN; LIPIDS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

EID: 84855849803     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029688     Document Type: Article

References (67)

1. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, et al. (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1: 398-401.
2. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, et al. (2000) Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 105: 497-504.
3. Vives-Pi M, Somoza N, Fernandez-Alvarez J, Vargas F, Caro P, et al. (2003) Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol 133: 208-218.
4. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, et al. (2000) Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 275: 11058-11063.
5. Nicola JP, Velez ML, Lucero AM, Fozzatti L, Pellizas CG, et al. (2009) Functional toll-like receptor 4 conferring lipopolysaccharide responsiveness is expressed in thyroid cells. Endocrinology 150: 500-508.
6. Reyes TM, Walker JR, DeCino C, Hogenesch JB, Sawchenko PE, (2003) Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci 23: 5607-5616.
7. Thaler JP, Choi SJ, Sajan MP, Ogimoto K, Nguyen HT, et al. (2009) Atypical Protein Kinase C Activity in the Hypothalamus Is Required for Lipopolysaccharide-Mediated Sickness Responses. Endocrinology.
8. Rorato R, Castro M, Borges BC, Benedetti M, Germano CM, et al. (2008) Adrenalectomy enhances endotoxemia-induced hypophagia: higher activation of corticotrophin-releasing-factor and proopiomelanocortin hypothalamic neurons. Horm Behav 54: 134-142.
9. Bienkowski MS, Rinaman L, (2008) Noradrenergic inputs to the paraventricular hypothalamus contribute to hypothalamic-pituitary-adrenal axis and central Fos activation in rats after acute systemic endotoxin exposure. Neuroscience 156: 1093-1102.
10. Muthu K, He LK, Szilagyi A, Strotmon P, Gamelli RL, et al. (2010) ss-adrenergic stimulation increases macrophage CD14 expression and E. coli phagocytosis through PKA signaling mechanisms. J Leukoc Biol 88: 715-724.
11. Vitseva OI, Tanriverdi K, Tchkonia TT, Kirkland JL, McDonnell ME, et al. (2008) Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 16: 932-937.
12. Xu XH, Shah PK, Faure E, Equils O, Thomas L, et al. (2001) Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104: 3103-3108.
13. McCartney-Francis N, Jin W, Wahl SM, (2004) Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-beta 1 signaling pathway. J Immunol 172: 3814-3821.
14. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, et al. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42-47.
15. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, et al. (2000) Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23: 1835-1839.
16. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP, (2000) Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 152: 897-907.
17. Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, et al. (2001) C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 104: 145-150.
18. Berg AH, Scherer PE, (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96: 939-949.
19. Bo S, Gambino R, Uberti B, Mangiameli MP, Colosso G, et al. (2005) Does C-reactive protein identify a subclinical metabolic disease in healthy subjects? Eur J Clin Invest 35: 265-270.
20. Wellen KE, Hotamisligil GS, (2005) Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119.
21. Gonzalez AS, Guerrero DB, Soto MB, Diaz SP, Martinez-Olmos M, et al. (2006) Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr 60: 802-809.
22. Pickup JC, Crook MA, (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-1248.
23. DiPenta JM, Green-Johnson JM, Murphy RJ, (2007) Type 2 diabetes mellitus, resistance training, and innate immunity: is there a common link? Appl Physiol Nutr Metab 32: 1025-1035.
24. Schertzer JD, Tamrakar AK, Magalhaes JG, Pereira S, Bilan PJ, et al. (2011) NOD1 activators link innate immunity to insulin resistance. Diabetes 60: 2206-2215.
25. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
26. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
27. Ding S, Lund PK, (2011) Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 14: 328-333.
28. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015-3025.
29. Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, et al. (2007) Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circulation research 100: 1589-1596.
30. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752.
31. Moore KJ, Andersson LP, Ingalls RR, Monks BG, Li R, et al. (2000) Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol 165: 4272-4280.
32. Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM, et al. (2009) Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol 83: 1492-1500.
33. Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, et al. (2004) Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 114: 1281-1289.
34. Kohsaka A, Laposky AD, Ramsey KM, Estrada C, Joshu C, et al. (2007) High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 6: 414-421.
35. Morrow LA, Morganroth GS, Herman WH, Bergman RN, Halter JB, (1993) Effects of epinephrine on insulin secretion and action in humans. Interaction with aging. Diabetes 42: 307-315.
36. Altorfer RM, Ziegler WH, Froesch ER, (1981) Insulin hypoglycaemia in normal and adrenalectomized subjects: comparison of metabolic parameters and endocrine counter regulation. Acta Endocrinol (Copenh) 98: 413-419.
37. Shire JG, Spickett SG, (1968) Genetic variation in adrenal structure: strain differences in quantitative characters. The Journal of endocrinology 40: 215-229.
38. Kobayashi K, Sasaoka T, Morita S, Nagatsu I, Iguchi A, et al. (1992) Genetic alteration of catecholamine specificity in transgenic mice. Proc Natl Acad Sci U S A 89: 1631-1635.
39. Wittmers LE Jr, Haller EW, (1983) Effect of adrenalectomy on the metabolism of glucose in obese (C57 Bl/6J ob/ob) mice. Metabolism 32: 1093-1100.
40. Solomon J, Bradwin G, Cocchia MA, Coffey D, Condon T, et al. (1977) Effects of adrenalectomy on body weight and hyperglycemia in five months old Ob/Ob mice. Horm Metab Res 9: 152-156.
41. Ohshima K, Shargill NS, Chan TM, Bray GA, (1984) Adrenalectomy reverses insulin resistance in muscle from obese (ob/ob) mice. Am J Physiol 246: E193-197.
42. Coelho MM, Souza GE, Pela IR, (1992) Endotoxin-induced fever is modulated by endogenous glucocorticoids in rats. Am J Physiol 263: R423-427.
43. Ramachandra RN, Sehon AH, Berczi I, (1992) Neuro-hormonal host defence in endotoxin shock. Brain Behav Immun 6: 157-169.
44. Lang CH, Spolarics Z, Ottlakan A, Spitzer JJ, (1993) Effect of high-dose endotoxin on glucose production and utilization. Metabolism 42: 1351-1358.
45. Virkamaki A, Yki-Jarvinen H, (1994) Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134: 2072-2078.
46. Bornstein SR, Zacharowski P, Schumann RR, Barthel A, Tran N, et al. (2004) Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc Natl Acad Sci U S A 101: 16695-16700.
47. Zacharowski K, Zacharowski PA, Koch A, Baban A, Tran N, et al. (2006) Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc Natl Acad Sci U S A 103: 6392-6397.
48. Matsuzaki J, Kuwamura M, Yamaji R, Inui H, Nakano Y, (2001) Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice. J Nutr 131: 2139-2144.
49. van Enckevort FH, Sweep CG, Span PN, Demacker PN, Hermsen CC, et al. (2001) Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice. J Endocrinol Invest 24: 786-795.
50. Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME, (2008) Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity 16: 1248-1255.
51. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, et al. (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56: 1986-1998.
52. Shah PK, (2007) Innate immune pathway links obesity to insulin resistance. Circulation research 100: 1531-1533.
53. Poggi M, Bastelica D, Gual P, Iglesias MA, Gremeaux T, et al. (2007) C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50: 1267-1276.
54. Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, et al. (2011) Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. The Journal of clinical investigation 121: 1858-1870.
55. Erridge C, Samani NJ, (2009) Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arteriosclerosis, thrombosis, and vascular biology 29: 1944-1949.
56. Schaeffler A, Gross P, Buettner R, Bollheimer C, Buechler C, et al. (2009) Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126: 233-245.
57. Sadeghi S, Wallace FA, Calder PC, (1999) Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology 96: 404-410.
58. Holzer RG, Park EJ, Li N, Tran H, Chen M, et al. (2011) Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 147: 173-184.
59. Samuel VT, Petersen KF, Shulman GI, (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375: 2267-2277.
60. Brea D, Sobrino T, Rodriguez-Yanez M, Ramos-Cabrer P, Agulla J, et al. (2011) Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke. Clin Immunol 139: 193-198.
61. Rallabhandi P, Awomoyi A, Thomas KE, Phalipon A, Fujimoto Y, et al. (2008) Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling. Journal of immunology 180: 1139-1147.
62. Prohinar P, Rallabhandi P, Weiss JP, Gioannini TL, (2010) Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wild-type TLR4. Journal of immunology 184: 4362-4367.
63. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191.
64. Ferwerda B, McCall MB, Alonso S, Giamarellos-Bourboulis EJ, Mouktaroudi M, et al. (2007) TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proceedings of the National Academy of Sciences of the United States of America 104: 16645-16650.
65. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, et al. (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347: 185-192.
66. Cuda C, Badawi A, Karmali M, El-Sohemy A, (2011) Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol. Metabolism: clinical and experimental 60: 1131-1135.
67. Weyrich P, Staiger H, Stancakova A, Machicao F, Machann J, et al. (2010) The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies. PloS one 5: e13980.